| Sign In to gain access to subscriptions and/or personal tools. |
Liver Disease and OsteoporosisDivision of Gastroenterology, Hepatology, and Liver Transplantation, Mayo Clinic Foundation, Jacksonville, Florida Correspondence: Jaime Aranda-Michel, MD, Division of Gastroenterology, Hepatology, and Liver Transplantation, Mayo Clinic Foundation, Jacksonville, FL. Electronic mail may be sent to arandamichel.jaime{at}mayo.edu. Metabolic bone disease (osteodystrophy) is an important complication of patients with chronic liver disease; its etiology is complex and multifactorial. Osteodystrophy is manifested as osteopenia/osteoporosis. Osteoporosis can predispose patients to bone fractures, increasing morbidity and mortality, especially after liver transplantation. Early evaluation, screening, and treatment of bone disorders in patients with liver disease are essential to minimize fracture risk and to improve clinical outcome and quality of life.
Nutrition in Clinical Practice, Vol. 21, No. 3,
273-278 (2006) This article has been cited by other articles:
|
|
|||||||||||||||


